唠叨 发表于 2025-3-26 21:27:18

http://reply.papertrans.cn/19/1898/189734/189734_31.png

切掉 发表于 2025-3-27 04:24:54

http://reply.papertrans.cn/19/1898/189734/189734_32.png

考博 发表于 2025-3-27 07:18:59

http://reply.papertrans.cn/19/1898/189734/189734_33.png

Gratuitous 发表于 2025-3-27 10:22:52

https://doi.org/10.1057/9780230511484tem/progenitor cells (HSPC) are the most frequently cells used in preclinical and clinical neurorestorative studies in stroke therapy. Therefore co-transplantation of BM MSCs with other cells may be a better strategy to improve microenvironment, make the grafting more efficient, and improve function

Alpha-Cells 发表于 2025-3-27 15:25:20

http://reply.papertrans.cn/19/1898/189734/189734_35.png

笨拙的我 发表于 2025-3-27 19:14:44

http://reply.papertrans.cn/19/1898/189734/189734_36.png

Limousine 发表于 2025-3-27 23:23:22

http://reply.papertrans.cn/19/1898/189734/189734_37.png

寻找 发表于 2025-3-28 05:45:14

Co-transplantation Strategies and Combination Therapies for Stroke,tem/progenitor cells (HSPC) are the most frequently cells used in preclinical and clinical neurorestorative studies in stroke therapy. Therefore co-transplantation of BM MSCs with other cells may be a better strategy to improve microenvironment, make the grafting more efficient, and improve function

信条 发表于 2025-3-28 06:48:16

http://reply.papertrans.cn/19/1898/189734/189734_39.png

翻布寻找 发表于 2025-3-28 12:51:50

http://reply.papertrans.cn/19/1898/189734/189734_40.png
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: Bone marrow stem cell therapy for stroke; Kunlin Jin,Xunming Ji,Qichuan Zhuge Book 2017 Springer Nature Singapore Pte Ltd. 2017 bone marro